These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 9215399

  • 1. Effects of retinoid X receptor-selective ligands on proliferation of prostate cancer cells.
    de Vos S, Dawson MI, Holden S, Le T, Wang A, Cho SK, Chen DL, Koeffler HP.
    Prostate; 1997 Jul 01; 32(2):115-21. PubMed ID: 9215399
    [Abstract] [Full Text] [Related]

  • 2. Effects of novel retinoid X receptor-selective ligands on myeloid leukemia differentiation and proliferation in vitro.
    Kizaki M, Dawson MI, Heyman R, Elster E, Morosetti R, Pakkala S, Chen DL, Ueno H, Chao W, Morikawa M, Ikeda Y, Heber D, Pfahl M, Koeffler HP.
    Blood; 1996 Mar 01; 87(5):1977-84. PubMed ID: 8634447
    [Abstract] [Full Text] [Related]

  • 3. Retinoic acid receptor- and retinoid X receptor-selective retinoids activate signaling pathways that converge on AP-1 and inhibit squamous differentiation in human bronchial epithelial cells.
    Lee HY, Dawson MI, Walsh GL, Nesbitt JC, Eckert RL, Fuchs E, Hong WK, Lotan R, Kurie JM.
    Cell Growth Differ; 1996 Aug 01; 7(8):997-1004. PubMed ID: 8853895
    [Abstract] [Full Text] [Related]

  • 4. Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro.
    Shiohara M, Dawson MI, Hobbs PD, Sawai N, Higuchi T, Koike K, Komiyama A, Koeffler HP.
    Blood; 1999 Mar 15; 93(6):2057-66. PubMed ID: 10068679
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids.
    Wu Q, Dawson MI, Zheng Y, Hobbs PD, Agadir A, Jong L, Li Y, Liu R, Lin B, Zhang XK.
    Mol Cell Biol; 1997 Nov 15; 17(11):6598-608. PubMed ID: 9343423
    [Abstract] [Full Text] [Related]

  • 6. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
    Agarwal C, Chandraratna RA, Teng M, Nagpal S, Rorke EA, Eckert RL.
    Cell Growth Differ; 1996 Apr 15; 7(4):521-30. PubMed ID: 9052993
    [Abstract] [Full Text] [Related]

  • 7. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells.
    Sun SY, Yue P, Dawson MI, Shroot B, Michel S, Lamph WW, Heyman RA, Teng M, Chandraratna RA, Shudo K, Hong WK, Lotan R.
    Cancer Res; 1997 Nov 01; 57(21):4931-9. PubMed ID: 9354460
    [Abstract] [Full Text] [Related]

  • 8. Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical epithelial cells.
    Hembree JR, Agarwal C, Beard RL, Chandraratna RA, Eckert R.
    Cancer Res; 1996 Apr 15; 56(8):1794-9. PubMed ID: 8620495
    [Abstract] [Full Text] [Related]

  • 9. Myeloid differentiation mediated through retinoic acid receptor/retinoic X receptor (RXR) not RXR/RXR pathway.
    Dawson MI, Elstner E, Kizaki M, Chen DL, Pakkala S, Kerner B, Koeffler HP.
    Blood; 1994 Jul 15; 84(2):446-52. PubMed ID: 8025272
    [Abstract] [Full Text] [Related]

  • 10. Retinoids selective for retinoid X receptor response pathways.
    Lehmann JM, Jong L, Fanjul A, Cameron JF, Lu XP, Haefner P, Dawson MI, Pfahl M.
    Science; 1992 Dec 18; 258(5090):1944-6. PubMed ID: 1335166
    [Abstract] [Full Text] [Related]

  • 11. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
    Sun SY, Yue P, Mao L, Dawson MI, Shroot B, Lamph WW, Heyman RA, Chandraratna RA, Shudo K, Hong WK, Lotan R.
    Clin Cancer Res; 2000 Apr 18; 6(4):1563-73. PubMed ID: 10778990
    [Abstract] [Full Text] [Related]

  • 12. Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors.
    Zacheis D, Dhar A, Lu S, Madler MM, Klucik J, Brown CW, Liu S, Clement F, Subramanian S, Weerasekare GM, Berlin KD, Gold MA, Houck JR, Fountain KR, Benbrook DM.
    J Med Chem; 1999 Oct 21; 42(21):4434-45. PubMed ID: 10543887
    [Abstract] [Full Text] [Related]

  • 13. Increased retinoic acid responsiveness in lung carcinoma cells that are nonresponsive despite the presence of endogenous retinoic acid receptor (RAR) beta by expression of exogenous retinoid receptors retinoid X receptor alpha, RAR alpha, and RAR gamma.
    Wan H, Hong WK, Lotan R.
    Cancer Res; 2001 Jan 15; 61(2):556-64. PubMed ID: 11212249
    [Abstract] [Full Text] [Related]

  • 14. Greater synergism of retinoic acid receptor (RAR) agonists with vitamin D3 than that of retinoid X receptor (RXR) agonists with regard to growth inhibition and differentiation induction in monoblastic leukemia cells.
    Makishima M, Shudo K, Honma Y.
    Biochem Pharmacol; 1999 Mar 01; 57(5):521-9. PubMed ID: 9952315
    [Abstract] [Full Text] [Related]

  • 15. Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status.
    Fitzgerald P, Teng M, Chandraratna RA, Heyman RA, Allegretto EA.
    Cancer Res; 1997 Jul 01; 57(13):2642-50. PubMed ID: 9205071
    [Abstract] [Full Text] [Related]

  • 16. Potentiation of VD-induced monocytic leukemia cell differentiation by retinoids involves both RAR and RXR signaling pathways.
    Defacque H, Sévilla C, Piquemal D, Rochette-Egly C, Marti J, Commes T.
    Leukemia; 1997 Feb 01; 11(2):221-7. PubMed ID: 9009084
    [Abstract] [Full Text] [Related]

  • 17. Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity.
    Muccio DD, Brouillette WJ, Alam M, Vaezi MF, Sani BP, Venepally P, Reddy L, Li E, Norris AW, Simpson-Herren L, Hill DL.
    J Med Chem; 1996 Sep 13; 39(19):3625-35. PubMed ID: 8809153
    [Abstract] [Full Text] [Related]

  • 18. Effects of novel retinoic acid compound, 9-cis-retinoic acid, on proliferation, differentiation, and expression of retinoic acid receptor-alpha and retinoid X receptor-alpha RNA by HL-60 cells.
    Kizaki M, Ikeda Y, Tanosaki R, Nakajima H, Morikawa M, Sakashita A, Koeffler HP.
    Blood; 1993 Dec 15; 82(12):3592-9. PubMed ID: 8260698
    [Abstract] [Full Text] [Related]

  • 19. Identification of a novel class of retinoic acid receptor beta-selective retinoid antagonists and their inhibitory effects on AP-1 activity and retinoic acid-induced apoptosis in human breast cancer cells.
    Li Y, Hashimoto Y, Agadir A, Kagechika H, Zhang Xk.
    J Biol Chem; 1999 May 28; 274(22):15360-6. PubMed ID: 10336422
    [Abstract] [Full Text] [Related]

  • 20. Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor alpha (RAR alpha)-, RAR beta-, or RAR gamma-selective ligand in combination with a retinoid X receptor-specific ligand.
    Roy B, Taneja R, Chambon P.
    Mol Cell Biol; 1995 Dec 28; 15(12):6481-7. PubMed ID: 8524212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.